CHATPRIVACYDONATELOGINREGISTER
DMT-Nexus
FAQWIKIHEALTH & SAFETYARTATTITUDEACTIVE TOPICS
Usona Institute Breaks Ground for Global Center in Psychedelic Science Options
 
muladharma
#1 Posted : 10/8/2021 7:23:19 PM

DMT-Nexus member


Posts: 128
Joined: 03-Jun-2017
Last visit: 14-Jun-2022
Location: European Union
Article from 03.08.2021
https://www.businesswire.com/news/home/20210803006191/en
Find the wisdom to practice loving-kindness.
 

Live plants. Sustainable, ethically sourced, native American owned.
 
The Traveler
#2 Posted : 10/8/2021 7:45:55 PM

"No, seriously"

Administrator | Skills: DMT, LSD, Programming

Posts: 7324
Joined: 18-Jan-2007
Last visit: 02-Nov-2024
Location: Orion Spur
And that article is related to this one:

https://pharmacy.wisc.ed...-for-medical-treatments/

School of Pharmacy wrote:
Based at the UW School of Pharmacy, the UW–Madison Transdisciplinary Center for Research in Psychoactive Substances brings together leading scientists on the forefront of psychedelic research

University of Wisconsin–Madison School of Pharmacy Professor Paul Hutson serves as the founding director of the UW Transdisciplinary Center for Research in Psychoactive Substances
The University of Wisconsin–Madison is launching a new research center to coordinate ongoing research and education in psychedelic compounds, as evidence grows for their utility in treating substance abuse and psychiatric disorders, such as major depression and post-traumatic stress disorder (PTSD).

Housed within the UW–Madison School of Pharmacy, the Transdisciplinary Center for Research in Psychoactive Substances will conduct scholarly research into the science, history, and cultural impact of psychedelic agents, in addition to studying the potential for therapeutic use of psychoactive substances. This center will expand the scope and reach of the psychedelic research enterprise at UW–Madison to build on clinical studies that have been active on campus since 2014.

“From cannabis to psilocybin (magic mushrooms) and MDMA (ecstasy), psychoactive agents are the new frontier for potential new therapies and medications,” says Paul Hutson, founding center director and UW–Madison School of Pharmacy professor.



Kind regards,

The Traveler
 
 
Users browsing this forum
Guest

DMT-Nexus theme created by The Traveler
This page was generated in 0.032 seconds.